Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
2011

miR-101 and EZH2 in Blood Vessel Formation

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Smits Michiel, Mir Shahryar E., Nilsson R. Jonas A., van der Stoop Petra M., Niers Johanna M., Marquez Victor E., Cloos Jacqueline, Breakefield Xandra O., Krichevsky Anna M., Noske David P., Tannous Bakhos A., Würdinger Thomas

Primary Institution: VU University Medical Center, Amsterdam, The Netherlands

Hypothesis

The study investigates the role of miR-101 in regulating EZH2 and its impact on angiogenesis.

Conclusion

Inhibition of EZH2 can reduce blood vessel formation in glioblastomas, suggesting a potential therapeutic approach.

Supporting Evidence

  • VEGF down-regulates miR-101, leading to increased EZH2 expression.
  • Inhibition of EZH2 reduces tubule formation in endothelial cells.
  • Systemic administration of DZNep reduces blood vessel formation in glioblastoma models.
  • miR-101 directly targets EZH2, confirming its regulatory role.

Takeaway

This study shows that a tiny molecule called miR-101 helps control another molecule, EZH2, which is important for making new blood vessels. If we can stop EZH2, we might be able to help treat certain cancers.

Methodology

The study used in vitro experiments with primary endothelial cells and in vivo mouse models to assess the effects of miR-101 and EZH2 on angiogenesis.

Limitations

The study was conducted in an immune-compromised mouse model, which may not fully represent the human immune response.

Participant Demographics

The study involved human brain microvascular endothelial cells and glioblastoma samples from patients.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016282

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication